30 results
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
be offset by certain U.S. source capital losses of the non-U.S. holder provided the non-U.S. holder has timely filed U.S. federal income tax returns
424B5
VERV
Verve Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:25pm
be offset by certain U.S. source capital losses of the non-U.S. holder provided the non-U.S. holder has timely filed U.S. federal income tax returns
S-3ASR
bnyrbt ytda65wa
23 Sep 22
Automatic shelf registration
4:08pm
424B5
k43h9x
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
7ut98
20 Jul 22
Prospectus supplement for primary offering
4:22pm
DEF 14A
i0dunpq0mzwo94
29 Apr 22
Definitive proxy
7:01am
10-K
h4xbwmbgsu g213tw
14 Mar 22
Annual report
7:04am